This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Glycopyrrolate Injection (2016-10-17)

Starting date:
October 17, 2016
Posting date:
November 8, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-60926

Affected Products

Reason

Some 1-mL vials packaged in 2-ml format boxes.

Depth of distribution

Wholesalers and pharmacies in Canada

Affected products

Glycopyrrolate Injection

DIN, NPN, DIN-HIM
DIN 02382857
Dosage form

Liquid (Injectable)

Strength

0.2 mg/mL Glycopyrrolate

Lot or serial number

6D329

Companies
Recalling Firm
Omega Laboratories Ltd.
11177 Hamon
Montreal
H3M 3E4
Quebec
CANADA
Marketing Authorization Holder
Omega Laboratories Ltd.
11177 Hamon
Montreal
H3M 3E4
Quebec
CANADA

Date modified: